Transforming the Future of Cell Therapies
CellRep pioneers dynamic cell reprogramming without gene editing, revolutionizing how cell therapies work. Our AI-powered platform discovers and validates compounds that enhance cellular function, addressing three critical limitations in current CAR-T therapies: poor efficacy in solid tumors, lengthy manufacturing time, and prohibitive costs. We're making personalized medicine truly scalable, starting with cancer treatments and soon expanding into longevity applications.
End-to-end pipeline from target discovery to preclinical validation of cell reprogramming strategies.
Our Technology and Platform
We have developed an innovative approach to enhance T cell functionality by reprogramming these cells to a rejuvenated state and with improved therapeutic potential.
Our platform includes:
Our platform includes:
Target and Drug Discovery
Bioinformatics and AI-driven discovery of druggable targets
In vitro Screening
Optimized drug screening platform to analyze biomarkers at the single-cell level.
Preclinical testing
Cutting-edge in vivo models for PoC studies
Every cell therapy product faces unique challenges during delivery. CellRep's discovery platform is tailored to identify the optimal intracellular targets and candidate compounds to enhance cell profiles and maximize therapy efficacy. CellRep's methodology identifies, tests, and protects molecules while defining customized best practices for each cell therapy manufacturer.